About: Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2012 (fr) наукова стаття, опублікована у вересні 2012 (uk) im September 2012 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2012 (ast) scientific article published on 01 September 2012 (en)
publication date	wds:Q57618842-2652166C-2CF2-4FAC-94EA-8C229145FC1D
publication date	2012-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57618842-082D816D-E5BC-4084-8C0F-1ED8D3E64F21
language of work or name	English
cites work	wds:Q57618842-86D6B6FD-9B07-44C2-A7C3-F9139F58D9F0
cites work	Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
author name string	wds:Q57618842-2569360E-0015-441D-9D6B-CCB7B298FEE5 wds:Q57618842-437AA984-BC1A-4D0C-A420-1002C436B61B wds:Q57618842-50FE5A4E-94E1-425E-9FF6-50922FB5F0AF wds:Q57618842-559E7249-0408-4617-A856-211F3AF94C27 wds:Q57618842-56AAC454-7075-4C35-985E-A7439CC5F937 wds:Q57618842-5806C689-7FA9-41B4-AF15-CC0AAC6867C4 wds:Q57618842-5D1FF847-5AFF-4F16-B35A-078997922397 wds:Q57618842-C085CC7A-D95F-4761-9D8C-B24C1DC37123
author name string	Pasquale Perrone-Filardi Pierluigi Costanzo Stefania Paolillo Carmen D'Amore Caterina Marciano Milena Cecere Francesca Musella Teresa Losco
rdfs:label	Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (en) Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (nl)
skos:prefLabel	Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (en) Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (nl)
name	Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (en) Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? (nl)
author	wds:Q57618842-0AA3FF47-D7A5-448E-A05B-82F020B2999C wds:Q57618842-22FC1AA6-DF07-44D9-807E-C86195F4B356
author	Gianluigi Savarese Paola Gargiulo
title	wds:Q57618842-A9D7959A-89F3-4215-B7C0-3112DE0C82B3
title	Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials (en)
page(s)	wds:Q57618842-A18BA381-DA3C-4E8E-B7AE-C2F1E0C3FD71
page(s)	1192-1201
instance of	wds:Q57618842-216bb3bd-0e51-4dd2-89b5-42aeca8d2cb5 wds:Q57618842-60083275-0562-4A21-9AC2-CDC5E0E57614
instance of	meta-analysis scholarly article
main subject	wds:Q57618842-F9691037-3433-40CD-8EFA-8DDE542B8C0B
main subject	Patients
PubMed ID	wds:Q57618842-34205C2F-DC9B-465D-A3E2-21547CA09CDC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22995024
PubMed ID	22995024
published in	wds:Q57618842-F99238BF-E39D-49D2-B394-5F018DA42416
published in	Journal of the American College of Cardiology
issue	wds:Q57618842-6A3457DB-9CE3-4965-B324-00D512672594
volume	wds:Q57618842-C113CC31-DCEE-4FAF-B5EA-FFDC98E5E7BC
issue	13
volume	60
DOI	wds:Q57618842-AF639AC4-98FA-49FD-86D6-07197080A538
DOI	http://dx.doi.org/10.1016/J.JACC.2012.01.083
DOI	10.1016/J.JACC.2012.01.083
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57618842
is cites work of	Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges Building the case for novel clinical trials in pulmonary arterial hypertension Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis Pulmonary arterial hypertension: the clinical syndrome Pulmonary arterial hypertension: challenges in translational research and a vision for change Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design? Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension Macitentan in pulmonary arterial hypertension: The SERAPHIN trial Treatment goals of pulmonary hypertension Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH). Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome Six-minute walk test in pulmonary arterial hypertension Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials Value of impedance cardiography during 6-minute walk test in pulmonary hypertension Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan The evolving landscape of combination therapy for pulmonary arterial hypertension. To assess exertional breathlessness you must exert the breathless Distinct loading conditions reveal various patterns of right ventricular adaptation Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension. Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension Biomarkers and prognostic indicators in pulmonary arterial hypertension Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes Updating clinical endpoint definitions.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software